Retinopathy of prematurity: a study of prevalence and risk factors

Abdel H A A Hakeem1, Gamal B Mohamed, Mohamed F Othman

  • 1Department of Pediatrics, Faculty of Medicine, Al Minia University, Egypt.

Insights

Retinopathy of prematurity (ROP) affects 19.2% of premature infants, with low gestational age and sepsis being key risk factors. Laser therapy effectively treats advanced ROP, preventing blindness.

Area of Science:

  • Neonatal Medicine
  • Ophthalmology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a critical complication of preterm infant care, posing a significant risk of blindness.
  • Early detection and intervention are crucial for managing ROP and preventing vision loss.

Purpose of the Study:

  • To determine the prevalence of ROP in preterm infants within a Neonatal Intensive Care Unit (NICU).
  • To identify risk factors associated with ROP development.
  • To evaluate the outcomes of ROP cases and the effectiveness of treatment.

Main Methods:

  • A prospective screening survey of 172 preterm infants (gestational age ≤32 weeks or birth weight ≤1500 g, or >32 weeks/1500 g with >7 days oxygen therapy).
  • Retinal evaluations using indirect ophthalmoscopy from the fourth postnatal week.
  • Univariate and multivariate analyses to assess perinatal risk factors.
  • Laser therapy for infants progressing to stage 3 ROP.

Main Results:

  • ROP prevalence was 19.2% (33 out of 172 infants).
  • Stage 3 ROP occurred in 6 infants, who received laser therapy.
  • Significant risk factors included low gestational age, sepsis, oxygen therapy, and frequent blood transfusions.
  • No significant association was found with sex, birth weight, or respiratory support methods.

Conclusions:

  • The study identified a 19.2% prevalence of ROP, highlighting low gestational age, sepsis, oxygen therapy, and blood transfusions as significant risk factors.
  • Laser therapy demonstrated effectiveness in treating ROP and preventing its progression.
  • A nationwide survey in Egypt is recommended to assess regional ROP prevalence differences.
Abstract